Register for Upcoming Webinar on DEC. 8 @ 11AM
2025 China NMPA Bluebook is here:
China’s Grand Pharmaceutical has announced that it entered into a subscription agreement with Canada’s Conavi Medical. The two companies also entered an exclusive distribution agreement for Conavi’s products. Pursuant to
Transenterix, a US-based medical device company that builds surgical robotics to improve minimally invasive surgery, has announced that it has entered into an agreement with China’s Great Belief International Limited
Beijing Unidiag Technology Co., Ltd, a Chinese medical device and reagent developer, has raised 10M+ RMB in Series A+ round from National Small and Medium-size Enterprises Development Fund (Shenzhen Guozhong
According to the statistics of China Medical Device Industry Association, in 2016, the annual output value of China’s medical device industry reached 276.5 billion yuan, an increase of 13% over
Mobile healthcare refers to the delivery of medical services and information through the use of mobile communication technologies. Achieve medical services “at your fingertips.” Compared with the traditional medical, mobile
According to Gartner, 30% of internal medical implants and devices in the medical field will use 3D printing technology by the year 2020. Considering China has become world’s 2nd larget
Ambient Clinical Analytics, a U.S. medical analytics company founded in 2013, just inked a cooperation agreement with Meehealth, a leading Chinese Health IT company that supports hospitals across China. In
According to a local news report, an 84-year-old man in China recently became the first patient in the world to receive a 3D-printed tantalum knee joint implant. The procedure took
China’s Point of Care Testing industry: A billion-dollar market and growing 20-30% annually The rapid growth of the Point of Care Testing Industry and the obvious advantages of primary medical institutions
China’s In Vitro Diagnosis (IVD) Market is an opportunity for U.S. companies to take their product offering overseas. Here is a current overview of the current market. Introduction In vitro
The 2017 China BioMed Innovation and Investment Conference (2017 CBIIC) was held in Suzhou China lately. It was co-hosted by Securities Association of China (SAC), China Pharmaceutical Innovation and Research
According to a recent market study conducted in China, over a third of Chinese adults are now suffering from high blood pressure. To make matters worse, only 5% of those